Albert Bourla, Pfizer CEO (John Thys, Pool via AP Images)
May 25, 2021 06:26 AM EDT
Deals
Bioregnum

The $70B ques­tion: What’s Pfiz­er go­ing to do with all that Covid vac­cine cash?

Pfiz­er’s lat­est deal a few days ago to sell Eu­rope 1.8 bil­lion dos­es of BioN­Tech’s mR­NA vac­cine — 900 mil­lion guar­an­teed and 900 mil­lion op­tioned …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times